
Opinion|Videos|May 28, 2025
Current Challenges in the Management of Bronchiectasis
Panelists discuss how the heterogeneity of bronchiectasis requires precise phenotyping and a treatable traits approach to address varying symptom profiles, from cough-predominant to shortness of breath–predominant presentations.
Advertisement
Episodes in this series

Clinical Brief: Challenges in Managing Heterogeneous Bronchiectasis Presentations
Main Discussion Topics
- Bronchiectasis presents heterogeneously in symptoms, etiology, and severity.
- Treatment approaches should be tailored to specific phenotypes.
- Different symptom presentations require different management priorities.
Key Points for Physicians
- Recognize common symptom phenotypes:
- Cough predominant: focus on airway clearance techniques
- Dyspnea predominant with minimal cough: emphasize exercise, nutrition, and pulmonary rehabilitation
- Frequent exacerbator: targeted antibiotic strategies and infection prevention
- Perform thorough diagnostic workup to identify underlying etiologies.
- Treat comorbidities such as reflux, aspiration, and sinus disease.
- Apply a “treatable traits” approach focusing on specific characteristics rather than using a one-size-fits-all strategy.
Notable Insights
The heterogeneity of bronchiectasis necessitates precision medicine approaches tailored to individual patient presentations rather than standardized treatment algorithms.
Clinical Significance
Recognizing and addressing the varied presentations of bronchiectasis through phenotype-specific approaches improves management outcomes and patient quality of life.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
2
Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD
3
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
4
SENTRY Trial Shows Survival, Spleen Benefits in Myelofibrosis: Claire Harrison, MD
5





